Onconetix Inc. (ONCO)
Onconetix Statistics
Share Statistics
Onconetix has 14.55M shares outstanding. The number of shares has increased by -34.85% in one year.
| Shares Outstanding | 14.55M |
| Shares Change (YoY) | -34.85% |
| Shares Change (QoQ) | 75.35% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 9.39M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 209.25K, so 1.44% of the outstanding shares have been sold short.
| Short Interest | 209.25K |
| Short % of Shares Out | 1.44% |
| Short % of Float | 2.23% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.09 and the forward PE ratio is null. Onconetix's PEG ratio is 0.
| PE Ratio | -0.09 |
| Forward PE | n/a |
| PS Ratio | 57.95 |
| Forward PS | null |
| PB Ratio | 0.06 |
| P/FCF Ratio | -0.25 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Onconetix.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34, with a Debt / Equity ratio of 0.17.
| Current Ratio | 0.34 |
| Quick Ratio | 0.32 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | -0.27 |
| Debt / FCF | -0.72 |
| Interest Coverage | -53.65 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $4.87K |
| Profits Per Employee | $-3.12M |
| Employee Count | 12 |
| Asset Turnover | 0 |
| Inventory Turnover | 3.26 |
Taxes
| Income Tax | -12.59K |
| Effective Tax Rate | 0.03% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 3.52, so Onconetix's price volatility has been higher than the market average.
| Beta | 3.52 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 2.77 |
| Relative Strength Index (RSI) | 23.73 |
| Average Volume (20 Days) | - |
Income Statement
In the last 12 months, Onconetix had revenue of 58.47K and earned -37.41M in profits. Earnings per share was -87.6.
| Revenue | 58.47K |
| Gross Profit | -1.13M |
| Operating Income | -36.03M |
| Net Income | -37.41M |
| EBITDA | -36.71M |
| EBIT | -36.75M |
| Earnings Per Share (EPS) | -87.6 |
Balance Sheet
The company has 4.55M in cash and 9.89M in debt, giving a net cash position of -5.33M.
| Cash & Cash Equivalents | 4.55M |
| Total Debt | 9.89M |
| Net Cash | -5.33M |
| Retained Earnings | -56.79M |
| Total Assets | 61.92M |
| Working Capital | -16.31M |
Cash Flow
In the last 12 months, operating cash flow was -13.58M and capital expenditures -55.04K, giving a free cash flow of -13.64M.
| Operating Cash Flow | -13.58M |
| Capital Expenditures | -55.04K |
| Free Cash Flow | -13.64M |
| FCF Per Share | -31.88 |
Margins
Gross margin is -1927.93%, with operating and profit margins of -61634.47% and -63986.48%.
| Gross Margin | -1927.93% |
| Operating Margin | -61634.47% |
| Pretax Margin | -64008.02% |
| Profit Margin | -63986.48% |
| EBITDA Margin | -62784.1% |
| EBIT Margin | -61634.47% |
| FCF Margin | -23323.46% |
Dividends & Yields
ONCO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ONCO.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 24, 2024. It was a backward split with a ratio of 1:40.
| Last Split Date | Sep 24, 2024 |
| Split Type | backward |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | -4.89 |
| Piotroski F-Score | 4 |